ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997

VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds

July 25, 2008

Obey Strikes Again, Earmarks NCI Positions

July 2, 1976

Fox Retirement Marks End of Era for NCI Construction Program

October 6, 1989

Wyngaarden Law With Appointment Report; DeVita Tells Congress “We’re Addressing The Issue Internally”

March 20, 1987

Guidelines Adopted For Pathology Review

February 22, 1980